Articles Tagged With:
-
Ethical Concerns if Cancer Drugs, and Science in General, are Overhyped
Half of the cancer drugs described with superlatives such as “breakthrough,” “groundbreaking” and “game-changer” were not yet approved as safe and effective, found a recent study.
-
Surprising Conflicts of Advisory Committee Speakers
Much attention has been paid to clinicians with financial ties to industry and resulting conflicts of interest, but patients who speak at public meetings also have financial ties, found a recent analysis.
-
Some Older, Chronically Ill Patients Don’t Realize They Have a Choice in Deciding Surgery
Patients and family members were surprised that postoperative recovery was so difficult, and lacked knowledge on advance directives and the fact that they could decline major surgery.
-
Virginia Declares Opioids a Public Health Emergency
The state health commissioner's order establishes standing naloxone precriptions for all state residents at all pharmacies.
-
Study: Dementia Declining Thanks to Education
Fewer Americans exhibited symptoms between 2000 and 2012, according to one research group.
-
Are PCSK9 Inhibitors and Statins More Effective When Administered Together?
Treating patients with a combination of two cholesterol-lowering drugs demonstrated strong efficacy in recent study.
-
Warning: Reactivation of Hepatitis B Virus Coinfection During Treatment of Chronic Hepatitis C Virus Infection
SYNOPSIS: Prior to initiation of hepatitis C virus treatment with direct-acting antivirals, patients should be screened for hepatitis B virus coinfection. Those who are hepatitis B virus-infected should receive ongoing monitoring for flares and reactivation of hepatitis B.
-
Vasopressin as a Single Vasopressor Agent in Patients with Septic Shock
SYNOPSIS: The use of vasopressin as a vasopressor for septic shock produced similar outcomes as the use of norepinephrine.
-
What Influences ICU Admission?
SYNOPSIS: There is widespread variability between hospitals in rates of ICU admission. High ICU utilization hospitals were more likely to use invasive procedures and incurred higher costs than low ICU utilization hospitals with no difference in mortality.
-
Reported Beta-lactam Allergy Is Associated with More Adverse Events Among Inpatients
SYNOPSIS: A prospective cohort study from three hospitals determined that patients who did not receive a preferred beta-lactam antibiotic were at greater risk for an adverse event (adjusted odds ratio, 3.1; 95% confidence interval, 1.28-7.89) compared to controls without a beta-lactam allergy.